Sensus Healthcare (SRTS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Sensus Healthcare Revenue Highlights


Latest Revenue (Y)

$24.41M

Latest Revenue (Q)

$8.84M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Sensus Healthcare Revenue by Period


Sensus Healthcare Revenue by Year

DateRevenueChange
2023-12-31$24.41M-45.20%
2022-12-31$44.53M64.68%
2021-12-31$27.04M182.37%
2020-12-31$9.58M-64.87%
2019-12-31$27.26M3.16%
2018-12-31$26.43M28.36%
2017-12-31$20.59M39.00%
2016-12-31$14.81M44.17%
2015-12-31$10.27M76.81%
2014-12-31$5.81M-44.55%
2013-12-31$10.48M-

Sensus Healthcare generated $24.41M in revenue during NA 2023, up -45.20% compared to the previous quarter, and up 92.35% compared to the same period a year ago.

Sensus Healthcare Revenue by Quarter

DateRevenueChange
2024-09-30$8.84M-4.33%
2024-06-30$9.24M-13.35%
2024-03-31$10.66M-15.14%
2023-12-31$12.57M222.37%
2023-09-30$3.90M-13.89%
2023-06-30$4.53M32.60%
2023-03-31$3.41M-73.95%
2022-12-31$13.11M45.45%
2022-09-30$9.01M-25.41%
2022-06-30$12.08M16.85%
2022-03-31$10.34M-20.63%
2021-12-31$13.03M135.75%
2021-09-30$5.53M1.90%
2021-06-30$5.42M76.61%
2021-03-31$3.07M-39.74%
2020-12-31$5.09M214.44%
2020-09-30$1.62M36.96%
2020-06-30$1.18M-29.56%
2020-03-31$1.68M-80.26%
2019-12-31$8.51M45.69%
2019-09-30$5.84M-21.87%
2019-06-30$7.48M37.52%
2019-03-31$5.44M-32.72%
2018-12-31$8.08M27.58%
2018-09-30$6.33M4.58%
2018-06-30$6.06M1.70%
2018-03-31$5.96M-7.95%
2017-12-31$6.47M34.91%
2017-09-30$4.80M-3.47%
2017-06-30$4.97M14.10%
2017-03-31$4.35M-10.72%
2016-12-31$4.88M46.56%
2016-09-30$3.33M-6.81%
2016-06-30$3.57M17.65%
2016-03-31$3.04M-20.97%
2015-12-31$3.84M82.23%
2015-09-30$2.11M-12.02%
2015-06-30$2.40M24.14%
2015-03-31$1.93M-

Sensus Healthcare generated $8.84M in revenue during Q3 2024, up -4.33% compared to the previous quarter, and up 195.25% compared to the same period a year ago.

Sensus Healthcare Revenue Breakdown


Sensus Healthcare Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Service$2.80M$3.17M$3.11M$4.13M$2.15M
Product$20.35M$1.01M$23.00K$5.45M$25.11M

Sensus Healthcare's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (87.91%), and Service (12.09%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Product$7.47M$8.07M$9.49M$13.92M$2.90M$3.52M$9.00K$282.00K$733.00K$-7.00K$4.39M$4.25M$1.67M$475.21K$69.58K$1.08M$7.91M---
Service$585.00K$367.00K$799.00K-$2.02M$306.00K$604.00K$857.00K$2.32M$746.00K$1.13M$1.17M$1.40M$795.97K$1.14M$1.11M$603.44K$602.45K--
RevenueMember---------$905.00$1.11M---------

Sensus Healthcare's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (92.74%), and Service (7.26%).

Sensus Healthcare Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22
CHINA$1.49M$2.45M
Other Member$45.00K$104.00K
IRELAND$135.00K-
GUATEMALA$190.00K-
UNITED STATES$22.28M$41.98M

Sensus Healthcare's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (92.29%), CHINA (6.18%), GUATEMALA (0.79%), IRELAND (0.56%), and Other Member (0.19%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Sep 21
CHINA$6.00K$572.00K$155.00K$611.00K$450.00K$300.00K$130.00K$968.00K$594.00K$170.00K
UNITED STATES$8.69M$8.67M$10.48M$11.68M$3.44M$3.89M$3.27M$12.07M$8.41M$5.34M
Other Member$3.00K$29.00K$29.00K$15.00K$10.00K$10.00K$10.00K$64.00K$9.00K-
ISRAEL$141.00K$11.00K--------
GUATEMALA----$190.00K$190.00K----
IRELAND----$135.00K$135.00K----

Sensus Healthcare's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (98.30%), ISRAEL (1.60%), CHINA (0.07%), and Other Member (0.03%).

Sensus Healthcare Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
AXGNAxoGen$159.01M$48.64M
KIDSOrthoPediatrics$148.73M$52.80M
SRDXSurmodics$126.08M$30.34M
RXSTRxSight$89.08M$45.41M
SGHTSight Sciences$81.06M$20.16M
LUNGPulmonx$68.67M$20.39M
NPCENeuroPace$65.42M$21.06M
IRIXIRIDEX$51.87M$11.58M
RCELAVITA Medical$50.56M$21.23M
LNSRLENSAR$42.16M$13.54M
CVRXCVRx$39.30M$13.37M
SSKNSTRATA Skin Sciences$33.36M$8.44M
SRTSSensus Healthcare$24.41M$8.84M
CLPTClearPoint Neuro$23.95M$8.12M
LUCDLucid Diagnostics$2.43M$1.17B
AIMDAinos$122.11K-
OFIXOrthofix Medical$100.00K$198.62M
NVNOenVVeno Medical--

SRTS Revenue FAQ


What is Sensus Healthcare’s yearly revenue?

Sensus Healthcare's yearly revenue for 2023 was $24.4M, representing a decrease of -45.20% compared to 2022. The company's yearly revenue for 2022 was $44.53M, representing an increase of 64.68% compared to 2021. SRTS's yearly revenue for 2021 was $27.04M, representing an increase of 182.37% compared to 2020.

What is Sensus Healthcare’s quarterly revenue?

Sensus Healthcare's quarterly revenue for Q3 2024 was $8.84M, a -4.33% decrease from the previous quarter (Q2 2024), and a 126.76% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $9.24M, a -13.35% decrease from the previous quarter (Q1 2024), and a 104.09% increase year-over-year (Q2 2023). SRTS's quarterly revenue for Q1 2024 was $10.66M, a -15.14% decrease from the previous quarter (Q4 2023), and a 212.33% increase year-over-year (Q1 2023).

What is Sensus Healthcare’s revenue growth rate?

Sensus Healthcare's revenue growth rate for the last 3 years (2021-2023) was -9.75%, and for the last 5 years (2019-2023) was -10.48%.

What are Sensus Healthcare’s revenue streams?

Sensus Healthcare's revenue streams in c 23 are Service, and Product. Service generated $2.8M in revenue, accounting 12.09% of the company's total revenue, down -11.88% year-over-year. Product generated $20.35M in revenue, accounting 87.91% of the company's total revenue, up 1904.63% year-over-year.

What is Sensus Healthcare’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Sensus Healthcare was Product. This segment made a revenue of $20.35M, representing 87.91% of the company's total revenue.